ARID1A and urinary bladder carcinoma: In accordance with the in vitro data, we did not observe differential EZH2 mRNA amounts comparing bladder carcinomas of the TCGA 2017 data set either showing high ARID1A mRNA levels or low ARID1A mRNA expression (Fig 4E).